Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for acute pain after laparoscopic or arthroscopic procedures
NCT06887959Phase 4Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of suzetrigine in acute pain, sponsored by Vertex Pharmaceuticals. Primary endpoint: Patient Global Assessment for Pain Control. Started Mar 2025; status: completed.
02
Drugs
suzetrigine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06887959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06887959.